Clostridioides difficile infection in thoroughbred horses in Japan from 2010 to 2021

Autor: Eri Uchida-Fujii, Hidekazu Niwa, Mitsutoshi Senoh, Haru Kato, Yuta Kinoshita, Hiroshi Mita, Takanori Ueno

Publikováno v: Scientific Reports, Vol 13, Iss 1, Pp 1-8 (2023)

Abstract We encountered 34 Clostridioides difficile (C. difficile) infection (CDI) cases among Thoroughbred horses in Japan from 2010 to 2021. Among them, 79.4% (27/34) either died or were euthanised. The risk factors associated with CDI and mortalit

Externí odkaz: https://doaj.org/article/018142ca436342b096c8ff08b46362c2

Fecal microbiota transplantation for recurrent infection in a patient with ulcerative colitis

Autor: Kosaku Nanki, Shinta Mizuno, Katsuyoshi Matsuoka, Keiko Ono, Shinya Sugimoto, Hiroki Kiyohara, Mari Arai, Moeko Nakashima, Kozue Takeshita, Keiichiro Saigusa, Mitsutoshi Senoh, Tadashi Fukuda, Makoto Naganuma, Haru Kato, Wataru Suda, Masahira Hattori, Takanori Kanai

Publikováno v: Intestinal Research, Vol 16, Iss 1, Pp 142-146 (2018)

Fecal microbiota transplantation (FMT) has been reported as a safe and effective therapy in patients with refractory and recurrent Clostridium difficile infection (CDI). FMT has also been reported as a promising therapy in patients with ulcerative co

Externí odkaz: https://doaj.org/article/9f8df3f986394870b5793a6e29f59786

Redefining Clostridioides difficile infection antibiotic response and clinical outcomes

Autor: Anne J Gonzales-Luna, Andrew M Skinner, Carolyn D Alonso, Emilio Bouza, Oliver A Cornely, Tim G J de Meij, Richard J Drew, Kevin W Garey, Dale N Gerding, Stuart Johnson, Stacy A Kahn, Haru Kato, Ciaran P Kelly, Colleen R Kelly, Larry K Kociolek, Ed J Kuijper, Thomas Louie, Thomas V Riley, Thomas J Sandora, Maria J G T Vehreschild, Mark H Wilcox, Erik R Dubberke

Publikováno v: The EXPAND Cdiff group 2023, ' Redefining Clostridioides difficile infection antibiotic response and clinical outcomes ', The Lancet Infectious Diseases . https://doi.org/10.1016/S1473-3099(23)00047-6

With the approval and development of narrow-spectrum antibiotics for the treatment of Clostridioides difficile infection (CDI), the primary endpoint for treatment success of CDI antibiotic treatment trials has shifted from treatment response at end o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::caac03cac7016bb23538faa490d630d0
https://doi.org/10.1016/s1473-3099(23)00047-6

Fatal fulminant Clostridioides difficile colitis caused by Helicobacter pylori eradication therapy; a case report

Autor: Takahito Nei, Haru Kato, Toru Takiguchi, Shoji Yokobori, Hiroyuki Yokota, Mitsutoshi Senoh, Kim Shiei, Jun Hagiwara

Publikováno v: Journal of Infection and Chemotherapy. 26:305-308

A 74-year-old male was referred to our critical care department for refractory severe watery diarrhea with advanced leukocytosis (over 70,000/μl) after multiple administrations of eradication therapy against Helicobacter pylori (HP). He was diagnose

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::324926155f8ef318934f62a46f912d28
https://doi.org/10.1016/j.jiac.2019.10.021

Molecular epidemiology of endemic Clostridioides difficile infection in Japan

Autor: Mitsutoshi Senoh, Haru Kato

Publikováno v: Anaerobe. 74:102510

We reviewed the molecular epidemiology of Clostridioides difficile infection (CDI) in Japan by reviewing articles in which typing analysis was performed on recovered C. difficile isolates. Most of the multicenter studies showed that the major prevale

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfff91f5abde33d533e8752ca2b73301
https://doi.org/10.1016/j.anaerobe.2021.102510